Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Plant Tissue Culture02:57

Plant Tissue Culture

41.4K
Plant tissue culture is widely used in both primary and applied science. Applications range from plant development studies to functional gene studies, crop improvement, commercial micropropagation, virus elimination, and conservation of rare species.
41.4K
Tissue Transplantation01:24

Tissue Transplantation

1.2K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune Biomarkers of Islet Transplant Rejection Revealed by Synthetic Immunological Niche.

bioRxiv : the preprint server for biology·2026
Same author

Islets co-engineered with thrombomodulin and CD47 achieve sustained survival in allogeneic recipients without chronic immunosuppression.

JCI insight·2026
Same author

Elucidating the Mechanisms of SA-4-1BBL-Mediated Cancer Immunoprevention Through Advanced Informatics Approaches.

Biomolecules·2026
Same author

Progesterone signaling in oviductal epithelial cells modulates the immune response to support preimplantation embryonic development.

Science advances·2025
Same author

Establishment of Translational Luciferase-Based Cancer Models to Evaluate Antitumoral Therapies.

International journal of molecular sciences·2024
Same author

Engineering Pancreatic Islets to Transiently Codisplay on Their Surface Thrombomodulin and CD47 Immunomodulatory Proteins as a Means of Mitigating Instant Blood-Mediated Inflammatory Reaction following Intraportal Transplantation.

Journal of immunology (Baltimore, Md. : 1950)·2024

Related Experiment Video

Updated: Mar 29, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K

Novel technologies to engineer graft for tolerance induction.

Kyle B Woodward1, Feng Wang, Hong Zhao

  • 1aDepartment of Microbiology and Immunology, Institute for Cellular Therapeutics, University of Louisville, Louisville, Kentucky, USA bOrgan Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Zhongshan, Guangzhou, China *Kyle B. Woodward and Feng Wang equally contributed to the writing of this article.

Current Opinion in Organ Transplantation
|December 3, 2015
PubMed
Summary

Engineered allografts with immunomodulatory molecules offer a new way to achieve transplant tolerance. This approach avoids chronic immunosuppression, enhancing graft survival and patient safety.

More Related Videos

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.7K
Scalable, Flexible, and Cost-Effective Seedling Grafting
09:33

Scalable, Flexible, and Cost-Effective Seedling Grafting

Published on: January 6, 2023

2.4K

Related Experiment Videos

Last Updated: Mar 29, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

15.0K
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

12.7K
Scalable, Flexible, and Cost-Effective Seedling Grafting
09:33

Scalable, Flexible, and Cost-Effective Seedling Grafting

Published on: January 6, 2023

2.4K

Area of Science:

  • Transplantation immunology
  • Biotechnology
  • Regenerative medicine

Background:

  • Allograft rejection remains a significant challenge in transplantation.
  • Current immunosuppressive therapies have limitations including toxicity, side effects, and hindered transplant tolerance.
  • Developing strategies to induce long-term graft survival without chronic immunosuppression is crucial.

Purpose of the Study:

  • To review novel technologies for inducing transplant tolerance.
  • To explore the use of engineered grafts with immunomodulatory molecules.
  • To discuss the potential of localized immunomodulation for achieving transplant tolerance.

Main Methods:

  • Engineering cells, tissues, or solid organ grafts with immunoregulatory biologics.
  • Modulating the graft microenvironment to favor immune tolerance.
  • Analyzing the ratio of T effector cells to regulatory T cells (CD4+CD25+FoxP3+).

Main Results:

  • Demonstrated feasibility of engineering grafts for long-term survival without chronic immunosuppression.
  • Engineering grafts successfully altered the T effector/regulatory T cell balance within the graft microenvironment.
  • Achieved localized tolerance induction and maintenance through graft modification.

Conclusions:

  • Biologic-engineered allografts represent a paradigm shift for achieving long-term graft survival.
  • Localized immunomodulation via graft engineering minimizes immunosuppression-related adverse effects.
  • This approach preserves immune competency for fighting infections and cancer.